Estrogen Receptors Are Identified in the Glioblastoma Cell Line UI38MG

Abstract

OBJECTIVE: The antiestrogen tamoxifen has been found to be effective in decreasing glioblas toma cell proliferation, but the mechanism underlying this effect and whether it is through the estrogen receptor (ER) is controversial. The objective of this study was to determine whether ERs are present in three human glioblastoma cell lines—HS683, U138MG, and JHN J889H—using the most sensitive techniques available.

METHODS: Ligand binding and flow cytometry were employed to identify estrogen and pro gesterone receptors. The reverse transcriptase-polymerase chain reaction was used to identify ER mRNA, and a novel reporter gene transfection assay demonstrated that the ER was capable of activating gene transcription.

RESULTS: U138MG glioblastoma cells contain ERs that are capable of increasing gene tran scription in response to estradiol. No ERs were found in HS683 or JHN J889H cells.

CONCLUSION: Tamoxifen may be acting through the ER in some glioblastoma cells. (J Soc Gynecol Invest 1994;1:238-44)

Keywords

Glioblastoma cells tamoxifen antiestrogens estrogen receptor estrogen gene transcription progesterone receptor ligand binding flow cytometry.

Get full access to this article

View all access options for this article.

References

Poisson M. , Pertuiset BF , Hauw J-J. , et al. Steroid hormone receptors in human meningiomas, gliomas and brain metastases. J Neurooncol 1983;1:179-89.

Brentani MM , Lopes MT , Martins VR , Plese JP Steroid receptors in intracranial tumors. Clin Neuropharmacol 1984;7:347-50.

Fujimoto M. , Yoshino E. , Hirakawa K. , Fujimoto J. , Tamaya T. Estrogen receptors in brain tumors. Clin Neuropharmacol 1984 ;7:357-62.

Whittle IR , Hawkins RA , Miller JD Sex hormone receptors in intracranial tumours and normal brain. Eur J Surg Oncol 1987;13:303-7.

Romic Stojković R , Jovančević M. , Santel DU , Grčević N. , Gamulin S. Sex steroid receptors in intracranial tumors. Cancer 1990;65:1968-70.

Pollack IF , Randall MS , Kristofik MP , Kelly RH , Selker RG , Vertosick FT Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res 1990;50:7134-8.

Vertosick FT , Selker RG , Pollack IF , Arena V. The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: Preliminary results in a series of "failed" patients. Neurosurgery 1992;30:897-903.

Su HD , Mazzei GJ , Vogler WR , Kuo JF Effects of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calciumdependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary. Biochem Pharmacol 1985;34:3649-53.

Owens RB , Smith HS , Nelson-Rees WA , Springer EL Epithelial cell cultures from normal and cancerous human tissues. J Natl Cancer Inst 1976;56:843-9.

10.

Ponten J. , Macintyre EH Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 1968; 74:465-86.

11.

Beckman G. , Beckman L. , Ponten J. , Westermark B. G-6-PD and PGM phenotypes of 16 continuous human tumor cell lines. Evidence against cross-contamination by HeLa cells. Hum Hered 1971;21:238-41.

12.

Tanaka K. , Testa JR Assessment of methods for the cytogenetic analysis of human solid tumors. J Natl Cancer Inst 1987;79:1287-93.

13.

Chirgwin JM , Przybyla AE , MacDonald RJ , Rutter WJ Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18: 5294-9.

14.

Green S. , Walter P. , Kumar V. , et al. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature 1986;320:134-9.

15.

Ponglikitmongkol M. , Green S. , Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J 1988;7:3385-8.

16.

Southern EM Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-17.

17.

Feherty P. , Farrer-Brown G. , Kellie AE Oestradiol receptors in carcinoma and benign disease of the breast: An in vitro assay. Br J Cancer 1971;25:697-710.

18.

Horwitz KB , McGuire WL Progesterone and progesterone receptors in experimental breast cancer . Cancer Res 1977; 37:1733-8.

19.

Burton K. A study of the conditions and mechanism of diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1956;62:315.

20.

Graham ML II, Krett NL , Miller LA , et al. T47Dco cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance . Cancer Res 1992;50:6208-17.

21.

Graham ML II, Smith JA , Jewett PB , Horwitz KB Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: Analysis of quantitative dual parameter flow cytometry. Cancer Res 1992;52:593-602.

22.

Graham ML II, Bunn PA Jr, Jewett PB , Gonzalez-Aller C. , Horwitz KB Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: Characterization of an assay in breast cancer cell lines . Cancer Res 1989;49:3934-42.

23.

Klein-Hitpass L. , Schorpp M. , Wagner U. , Ryffel GU An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 1986;46:1053-61.

24.

Leslie KK , Tasset D. , Horwitz KB Functional analysis of a mutant estrogen receptor isolated from T47Dco breast cancer cells. Am J Obstet Gynecol 1992 ;166:1053-61.

25.

Vegeto E. , Cocciolo MG , Raspagliesi F. , Piffanelli A. , Fontanelli R. , Maggi A. Regulation of progesterone receptor gene expression. Cancer Res 1990;50:5291-5.

26.

Eckert RL , Katzenellenbogen BS Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells . Cancer Res 1982;42:139-44.

27.

Nardulli AM , Greene GJ , O'Malley BW , Katzenellenbogen BS Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: Analysis of estrogen effects on progesterone synthesis and degradation. Endocrinology 1988;122:935-44.

28.

Horwitz KB , Mockus MB , Lessey BA Variant T47D human breast cancer cells with high progesterone receptor levels despite estrogen and antiestrogen resistance. Cell 1982;28:633-42.

29.

Nishida M. , Kasahara K. , Kaneko M. , Iwasaki H. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Nippon Sanka Fujinka Gakkai Zasshi 1985;37: 1103-11.

30.

Holinka CF , Hata H. , Kuramoto H. , Gurpide E. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa) . J Steroid Biochem 1986;24:85-9.

31.

Coezy E. , Borgna J-L. , Rochefort H. Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982;42:317-23.

32.

Cho H. , Katzenellenbogen BS Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol Endocrinol 1993;7:441-52.

33.

Dickson RB , Lippman ME Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 1987 ;8:29-43.

34.

Lippman ME , Dickson RB , Gelmann EP , et al. Mechanisms of estrogenic and antiestrogenic regulation of growth of human breast carcinoma. In: Klijin JGM , ed. Hormonal manipulation of cancer: Peptides, growth factors, and new (anti)steroidal agents. New York: Raven Press, 1987:381-403.